Cargando…

阿扎胞苷联合HA方案在急性髓系白血病诱导及挽救治疗中的疗效分析

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613494/
https://www.ncbi.nlm.nih.gov/pubmed/36709173
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.09.011
_version_ 1784820004555849728
collection PubMed
description
format Online
Article
Text
id pubmed-9613494
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-96134942022-11-16 阿扎胞苷联合HA方案在急性髓系白血病诱导及挽救治疗中的疗效分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2022-09 /pmc/articles/PMC9613494/ /pubmed/36709173 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.09.011 Text en 2022年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 短篇论著
阿扎胞苷联合HA方案在急性髓系白血病诱导及挽救治疗中的疗效分析
title 阿扎胞苷联合HA方案在急性髓系白血病诱导及挽救治疗中的疗效分析
title_full 阿扎胞苷联合HA方案在急性髓系白血病诱导及挽救治疗中的疗效分析
title_fullStr 阿扎胞苷联合HA方案在急性髓系白血病诱导及挽救治疗中的疗效分析
title_full_unstemmed 阿扎胞苷联合HA方案在急性髓系白血病诱导及挽救治疗中的疗效分析
title_short 阿扎胞苷联合HA方案在急性髓系白血病诱导及挽救治疗中的疗效分析
title_sort 阿扎胞苷联合ha方案在急性髓系白血病诱导及挽救治疗中的疗效分析
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613494/
https://www.ncbi.nlm.nih.gov/pubmed/36709173
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.09.011
work_keys_str_mv AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī
AT āzhābāogānliánhéhafāngànzàijíxìngsuǐxìbáixuèbìngyòudǎojíwǎnjiùzhìliáozhōngdeliáoxiàofēnxī